신장 조직 검사의 유용성
Percutaneous Kidney Biopsy: A Valuable Diagnostic Tool
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Percutaneous kidney biopsy is a valuable diagnostic tool for the pathological evaluation of renal diseases, particularly glomerular disorders. It is crucial for guiding treatment decisions when clinical and laboratory findings are uncertain. Since its introduction in the mid-20th century, percutaneous kidney biopsy has evolved from an initial blind approach, associated with higher complication rates, to advanced methods using real-time ultrasound or computed tomography guidance and spring-loaded biopsy needles. These advancements have significantly improved tissue sampling accuracy and minimized complications, establishing percutaneous kidney biopsy as a relatively safe diagnostic procedure. Despite these improvements, the invasive nature of the procedure emphasizes the importance of careful patient selection and operator expertise. Nephrologists, as the primary operators and performers of kidney biopsy, play a pivotal role in ensuring timely and appropriate patient care.
Abstract
Percutaneous kidney biopsy is a valuable diagnostic tool for the pathological evaluation of renal diseases, particularly glomerular disorders. It is crucial for guiding treatment decisions when clinical and laboratory findings are uncertain. Since its introduction in the mid-20th century, percutaneous kidney biopsy has evolved from an initial blind approach, associated with higher complication rates, to advanced methods using real-time ultrasound or computed tomography guidance and spring-loaded biopsy needles. These advancements have significantly improved tissue sampling accuracy and minimized complications, establishing percutaneous kidney biopsy as a relatively safe diagnostic procedure. Despite these improvements, the invasive nature of the procedure emphasizes the importance of careful patient selection and operator expertise. Nephrologists, as the primary operators and performers of kidney biopsy, play a pivotal role in ensuring timely and appropriate patient care.
참고문헌 (42)
- Iversen P, "Aspiration biopsy of the kidney", Am J Med, 11, pp.324~330 (1951)
- Kark RM, "Biopsy of kidney in prone position", Lancet, 266, pp.1047~1049 (1954)
- Hogan JJ, "The native kidney biopsy : update and evidence for best practice", Clin J Am Soc Nephrol, 11, pp.354~362 (2016)
- Kim D, "A randomized, prospective, comparative study of manual and automated renal biopsies", Am J Kidney Dis, 32, pp.426~431 (1998)
- Alshami A, "Indications for kidney biopsy in idiopathic childhood nephrotic syndrome", Pediatr Nephrol, 32, pp.1897~1905 (2017)
- Hussain F, "Renal biopsies in children : current practice and audit of outcomes", Nephrol Dial Transplant, 25, pp.485~489 (2010)
- Kidney Disease: Improving Global Outcomes (KDIGO)Glomerular Diseases Work Group, "KDIGO 2021 clinical practice guideline for the management of glomerular diseases", Kidney Int, 4(Suppl 4), pp.S1~S276 (2021)
- Bobart SA, "Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies", Kidney Int, 95, pp.429~438 (2019)
- Behnert A, "Antiphospholipase A2 receptor autoantibodies : a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy", J Immunol Res, 2014, pp.143274~ (2014)
- de Fallois J, "The diagnostic value of native kidney biopsy in low grade, subnephrotic, and nephrotic range proteinuria : a retrospective cohort study", PLoS One, 17, pp.e0273671~ (2022)
- Luciano RL, "Update on the native kidney biopsy : core curriculum 2019", Am J Kidney Dis, 73, pp.404~415 (2019)
- Saha MK, "Glomerular hematuria and the utility of urine microscopy : a review", Am J Kidney Dis, 80, pp.383~392 (2022)
- Dhaun N, "Utility of renal biopsy in the clinical management of renal disease", Kidney Int, 85, pp.1039~1048 (2014)
- Alkadi MM, "Kidney biopsy in patients with markedly reduced kidney function", Kidney Int Rep, 7, pp.2505~2508 (2022)
- Espinel E, "Renal biopsy in type 2 diabetic patients", J Clin Med, 4, pp.998~1009 (2015)
- Bajema IM, "Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis", Kidney Int, 56, pp.1751~1758 (1999)
- Kidney Disease : Improving Global Outcomes(KDIGO)Lupus Nephritis Work Group, "KDIGO 2024 clinical practice guideline for the management of lupus nephritis", Kidney Int, 105(Suppl 1), pp.S1~S69 (2024)
- Najafian B, "Approach to kidney biopsy : core curriculum 2022", Am J Kidney Dis, 80, pp.119~131 (2022)
- Williams WW, "Clinical role of the renal transplant biopsy", Nat Rev Nephrol, 8, pp.110~121 (2012)
- Patel IJ, "Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions", J Vasc Interv Radiol, 23, pp.727~736 (2012)
- Health, "Clinical competence in percutaneous renal biopsy", Ann Intern Med, 108, pp.301~303 (1988)
- MacGinley R, "KHA-CARI guideline recommendations for renal biopsy", Nephrology(Carlton), 24, pp.1205~1213 (2019)
- Mannucci PM, "Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia", N Engl J Med, 308, pp.8~12 (1983)
- Manno C, "Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy : a randomized controlled trial", Am J Kidney Dis, 57, pp.850~855 (2011)
- Lim CC, "Desmopressin acetate to prevent bleeding in percutaneous kidney biopsy : a systematic review", Intern Med J, 51, pp.571~579 (2021)
- Kriegshauser JS, "Risk of bleeding after native renal biopsy as a function of preprocedural systolic and diastolic blood pressure", J Vasc Interv Radiol, 26, pp.206~212 (2015)
- Shidham GB, "Clinical risk factors associated with bleeding after native kidney biopsy", Nephrology(Carlton), 10, pp.305~310 (2005)
- Song JH, "Percutaneous biopsy in diffuse renal disease : comparison of 18-and 14-gauge automated biopsy devices", J Vasc Interv Radiol, 9, pp.651~655 (1998)
- Zhan T, "Comparison of outcomes of an 18-gauge vs 16-gauge ultrasound-guided percutaneous renal biopsy : a systematic review and meta-analysis", Ren Fail, 45, pp.2257806~ (2023)
- Racusen LC, "The Banff 97 working classification of renal allograft pathology", Kidney Int, 55, pp.713~723 (1999)
- Walker PD, "Practice guidelines for the renal biopsy", Mod Pathol, 17, pp.1555~1563 (2004)
- Whittier WL, "Who should perform the percutaneous renal biopsy : a nephrologist or radiologist?", Semin Dial, 27, pp.243~245 (2014)
- Yuan CM, "Survey of kidney biopsy clinical practice and training in the United States", Clin J Am Soc Nephrol, 13, pp.718~725 (2018)
- Berns JS, "Performance of procedures by nephrologists and nephrology fellows at U. S. nephrology training programs", Clin J Am Soc Nephrol, 3, pp.941~947 (2008)
- Aggarwal S, "A comparison between kidney allograft biopsies performed by nephrologists and surgeons versus interventional radiologists", Cureus, 11, pp.e6315~ (2019)
- Emelianova D, "The evolution of performing a kidney biopsy : a single center experience comparing native and transplant kidney biopsies performed by interventional radiologists and nephrologists", BMC Nephrol, 23, pp.226~ (2022)
- Amodu A, "Nephrologists’ attitudes toward native kidney biopsy : a qualitative study", Kidney Med, 3, pp.1022~1031 (2021)
- Ishikawa E, "Ultrasonography as a predictor of overt bleeding after renal biopsy", Clin Exp Nephrol, 13, pp.325~331 (2009)
- Whittier WL, "Complications of the percutaneous kidney biopsy", Adv Chronic Kidney Dis, 19, pp.179~187 (2012)
- Whittier WL, "Timing of complications in percutaneous renal biopsy", J Am Soc Nephrol, 15, pp.142~147 (2004)
- Whittier WL, "Renal biopsy : update", Curr Opin Nephrol Hypertens, 13, pp.661~665 (2004)
- Poggio ED, "Systematic review and meta-analysis of native kidney biopsy complications", Clin J Am Soc Nephrol, 15, pp.1595~1602 (2020)